Company profile: Nanoplex Technologies
1.1 - Company Overview
Company description
- Provider of nanoparticle-based products for life science research, enabling ultra-sensitive molecular identification and quantitation, as well as authentication and tracking applications; focused on rapidly translating state-of-the-art nanoscience into practical, valuable products.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Nanoplex Technologies
US BioTek
HQ: United States
Website
- Description: Provider of CLIA-accredited immunology and chemistry testing services for clinicians worldwide, including food sensitivity (IgG, IgG4, IgA), food allergy (IgE), inhalant/aeroallergen (IgG, IgG4, IgA, IgE), microbiome, organic acids, and environmental pollutants testing, backed by over 30 years of experience in ELISA technology. Headquartered in Shoreline, Washington.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full US BioTek company profile →
Emulate
HQ: United States
Website
- Description: Provider of advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emulate company profile →
Dyadic
HQ: United States
Website
- Description: Provider of microbial protein production platforms and bio-based chemicals. Offers the C1 Platform for developing and manufacturing vaccines, antibodies, and therapeutic proteins for human and animal health; the Dapibus Platform for rapid, large-scale non-pharmaceutical proteins for food and nutrition; recombinant HSA, alpha-lactalbumin, and transferrin; and the DYAI-100 COVID-19 vaccine candidate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dyadic company profile →
Ethypharm
HQ: France
Website
- Description: Provider of pharmaceutical products for the treatment of pains and addictions, designing, formulating, developing, manufacturing, and marketing them.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ethypharm company profile →
BioDtech
HQ: United States
Website
- Description: Provider of reagents and systems for the detection, neutralization, and removal of endotoxin for researchers in bioresearch and bioprocess markets, offering detection solutions including EndoDtec-F to uncover bacteria in environmental samples, injectable drugs, and medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDtech company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Nanoplex Technologies
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Nanoplex Technologies
2.2 - Growth funds investing in similar companies to Nanoplex Technologies
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Nanoplex Technologies
4.2 - Public trading comparable groups for Nanoplex Technologies
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →